J. C. Blais

A phase II trial of oxaliplatin plus capecitabine (xelox) as second line therapy for patients with advanced pancreatic cancer.

K. Hess, R. Wolff, G. Varadhachary, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second‐line therapy for patients with advanced pancreatic cancer

K. Hess, R. Wolff, G. Varadhachary, 2008, Cancer.